ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
At a press conference at ESMO 2014, Dr Casali addresses the challenges of taking clinical decisions in rare cancers.
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes
The current status of multiple myeloma diagnosis and treatment
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC
Choosing Wisely to mitigate financial toxicity in cancer care in Africa